Surgery Partners Stock Current Ratio
| SGRY Stock | USD 24.53 0.47 1.88% |
Surgery Partners fundamentals help investors to digest information that contributes to Surgery Partners' financial success or failures. It also enables traders to predict the movement of Surgery Stock. The fundamental analysis module provides a way to measure Surgery Partners' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Surgery Partners stock.
| Last Reported | Projected for Next Year | ||
| Current Ratio | 1.71 | 1.91 |
Surgery | Current Ratio |
Surgery Partners Company Current Ratio Analysis
Surgery Partners' Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Surgery Partners Current Ratio | 1.51 X |
Most of Surgery Partners' fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Surgery Partners is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Surgery Current Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for Surgery Partners is extremely important. It helps to project a fair market value of Surgery Stock properly, considering its historical fundamentals such as Current Ratio. Since Surgery Partners' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Surgery Partners' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Surgery Partners' interrelated accounts and indicators.
Click cells to compare fundamentals
Surgery Current Ratio Historical Pattern
Today, most investors in Surgery Partners Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Surgery Partners' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current ratio growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Surgery Partners current ratio as a starting point in their analysis.
Surgery Partners Current Ratio |
| Timeline |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
Surgery Price To Sales Ratio
Price To Sales Ratio |
|
In accordance with the recently published financial statements, Surgery Partners has a Current Ratio of 1.51 times. This is 48.11% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current ratio for all United States stocks is 30.09% higher than that of the company.
Surgery Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Surgery Partners' direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Surgery Partners could also be used in its relative valuation, which is a method of valuing Surgery Partners by comparing valuation metrics of similar companies.Surgery Partners is currently under evaluation in current ratio category among related companies.
Surgery Fundamentals
| Return On Equity | 0.0407 | ||||
| Return On Asset | 0.0383 | ||||
| Profit Margin | (0) % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 7.35 B | ||||
| Shares Outstanding | 127.1 M | ||||
| Shares Owned By Insiders | 1.09 % | ||||
| Shares Owned By Institutions | 98.91 % | ||||
| Number Of Shares Shorted | 8.6 M | ||||
| Price To Earning | 61.84 X | ||||
| Price To Book | 1.68 X | ||||
| Price To Sales | 1.22 X | ||||
| Revenue | 2.74 B | ||||
| Gross Profit | 574.9 M | ||||
| EBITDA | 526.6 M | ||||
| Net Income | (11.9 M) | ||||
| Cash And Equivalents | 227.4 M | ||||
| Cash Per Share | 2.58 X | ||||
| Total Debt | 3.06 B | ||||
| Debt To Equity | 1.44 % | ||||
| Current Ratio | 1.51 X | ||||
| Book Value Per Share | 15.79 X | ||||
| Cash Flow From Operations | 293.8 M | ||||
| Short Ratio | 11.02 X | ||||
| Earnings Per Share | (0.09) X | ||||
| Price To Earnings To Growth | 1.66 X | ||||
| Target Price | 42.36 | ||||
| Number Of Employees | 10.5 K | ||||
| Beta | 2.74 | ||||
| Market Capitalization | 3.12 B | ||||
| Total Asset | 7.02 B | ||||
| Retained Earnings | (569.2 M) | ||||
| Working Capital | 372 M | ||||
| Current Asset | 310.96 M | ||||
| Current Liabilities | 181.29 M | ||||
| Net Asset | 7.02 B |
About Surgery Partners Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Surgery Partners's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Surgery Partners using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Surgery Partners based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Surgery Partners offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Surgery Partners' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Surgery Partners Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Surgery Partners Stock:Check out Surgery Partners Piotroski F Score and Surgery Partners Altman Z Score analysis. For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Surgery Stock analysis
When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Is Surgery Partners' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgery Partners. If investors know Surgery will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgery Partners listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.09) | Revenue Per Share 21.839 | Quarterly Revenue Growth 0.04 | Return On Assets 0.0383 | Return On Equity 0.0407 |
The market value of Surgery Partners is measured differently than its book value, which is the value of Surgery that is recorded on the company's balance sheet. Investors also form their own opinion of Surgery Partners' value that differs from its market value or its book value, called intrinsic value, which is Surgery Partners' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgery Partners' market value can be influenced by many factors that don't directly affect Surgery Partners' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surgery Partners' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgery Partners is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgery Partners' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.